---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-000166"
form_type: "8-K"
ticker: "CHRS"
cik: "0001512762"
company_name: "Coherus Oncology, Inc."
filed_at: "2024-01-10T23:59:59+00:00"
generated_at: "2026-06-07T00:55:06.783935+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Coherus presents preliminary unaudited FY2023 revenue at JPM conference; no specifics in filing

## Summary
- Preliminary unaudited FY2023 revenue presented at 42nd Annual J.P. Morgan Healthcare Conference.
- Financial closing procedures not yet complete; final results may materially differ.
- Independent registered public accounting firm has not reviewed the preliminary data.
- Filing includes cautionary note about the preliminary nature of the results.

## SEC filing metadata
- accession: 0001558370-24-000166
- form_type: 8-K
- ticker: CHRS
- cik: 0001512762
- company_name: Coherus Oncology, Inc.
- filed_at: 2024-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512762/000155837024000166/0001558370-24-000166-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512762/000155837024000166/chrs-20240110x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-000166
- JSON: https://secwatch.observer/filing/0001558370-24-000166.json
- Plain text: https://secwatch.observer/filing/0001558370-24-000166.txt

## Key facts
- Earnings Releases
  Coherus Oncology, Inc. reported preliminary financial results for fiscal year ended December 31, 2023.
  - Period: fiscal year ended December 31, 2023
  - Result: preliminary results
  source text: On January 10, 2024, Coherus BioSciences, Inc. (the “Company”) will present its preliminary unaudited revenue for the fiscal year ended December 31, 2023 in a public webcast presentation at the 42nd Annual J.P. Morgan Healthcare Conference. A copy of the preliminary financial information included in such presentation is furnished as Exhibit 99.1 to this report and will be available on the Company’s investor relations website at www.investors.coherus.com as previously announced.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1512762/000155837024000166/0001558370-24-000166-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.